The global radiotherapy market is expected to reach USD 9.47 Billion by 2022 from USD 6.81 Billion in 2017, at a CAGR of 6.8%. The growth of this market is majorly driven by rapidly increasing geriatric population, growing incidence of cancer cases across the globe, increasing symposiums driving investments in radiotherapy, and rising demand for radiotherapy devices.
With ongoing technological advancements towards the development of more effective, low-cost, and easy-to-use radiotherapy devices healthcare professionals are depending on these devices for high efficiency tumor targeting and reduced side-effects. The increasing government initiatives (aimed at equipping or upgrading hospitals with newer and advanced radiotherapy systems), increasing number of internal radiation therapy procedures (wherein radioactive seeds are used, and patients are required to be kept in isolation for a definite period of time), and growing adoption of radiotherapy devices and procedures are major factor supporting market growth.
Cancer research institutes utilize radiotherapy devices to develop imaging tools with high quality and accuracy aimed at providing better diagnostic and treatment solutions. The growing awareness about the research applications of radiotherapy devices, development of cost-effective and technologically advanced diagnostic and therapeutic radiotherapy systems are important growth drivers driving the demand for radiotherapy techniques.
Comments
Post a Comment